Financial results - HEBE-PHARM SRL

Financial Summary - Hebe-Pharm Srl
Unique identification code: 4169933
Registration number: J1993000580065
Nace: 4773
Sales - Ron
804.994
Net Profit - Ron
28.518
Employees
9
Open Account
Company Hebe-Pharm Srl with Fiscal Code 4169933 recorded a turnover of 2024 of 804.994, with a net profit of 28.518 and having an average number of employees of 9. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Hebe-Pharm Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 770.280 800.829 872.646 871.533 799.938 871.191 858.525 840.107 829.740 804.994
Total Income - EUR 826.741 824.421 894.473 926.346 899.983 922.440 895.525 840.121 1.029.550 804.996
Total Expenses - EUR 822.935 820.683 874.625 898.642 864.507 887.850 882.574 858.757 880.182 771.036
Gross Profit/Loss - EUR 3.806 3.739 19.848 27.704 35.475 34.590 12.951 -18.635 149.368 33.960
Net Profit/Loss - EUR 1.937 2.517 4.444 18.471 26.479 28.424 6.503 -24.844 123.622 28.518
Employees 11 13 14 13 11 11 11 10 10 9
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -2.4%, from 829.740 euro in the year 2023, to 804.994 euro in 2024. The Net Profit decreased by -94.413 euro, from 123.622 euro in 2023, to 28.518 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Hebe-Pharm Srl

Rating financiar

Financial Rating -
HEBE-PHARM SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Hebe-Pharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Hebe-Pharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Hebe-Pharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Hebe-Pharm Srl - CUI 4169933

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 250.606 245.320 272.894 257.708 218.368 203.482 186.919 222.861 210.355 208.759
Current Assets 328.291 301.605 335.348 324.930 316.138 408.887 423.319 379.175 314.005 277.543
Inventories 215.950 228.630 197.448 180.741 197.591 212.754 213.048 220.815 171.850 205.086
Receivables 52.835 47.106 113.106 137.598 107.053 173.766 190.261 136.689 130.777 70.766
Cash 59.506 25.869 24.794 6.591 11.494 22.367 20.010 21.670 11.378 1.691
Shareholders Funds 185.042 130.894 133.123 149.151 172.741 194.582 192.728 168.482 271.376 240.580
Social Capital 1.696 1.679 1.651 1.620 1.589 1.559 1.524 1.529 1.524 1.516
Debts 429.303 452.798 495.940 441.561 370.705 425.553 429.901 443.478 252.267 245.022
Income in Advance 0 0 0 0 0 0 0 0 716 700
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 277.543 euro in 2024 which includes Inventories of 205.086 euro, Receivables of 70.766 euro and cash availability of 1.691 euro.
The company's Equity was valued at 240.580 euro, while total Liabilities amounted to 245.022 euro. Equity decreased by -29.279 euro, from 271.376 euro in 2023, to 240.580 in 2024. The Debt Ratio was 50.4% in the year 2024.

Risk Reports Prices

Reviews - Hebe-Pharm Srl

Comments - Hebe-Pharm Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.